Ferguson, Daniel http://orcid.org/0000-0003-0336-8487
Finck, Brian N. http://orcid.org/0000-0001-5411-3674
Article History
Accepted: 29 April 2021
First Online: 15 June 2021
Competing interests
: B.N.F. is a stockholder and member of the scientific advisory board of Cirius Therapeutics Inc., which is developing MSDC-0602 for the treatment of NASH. D.F. declares no competing interests.